Related references
Note: Only part of the references are listed.Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy
Yen-Hung Lin et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome
Wojciech Kosmala et al.
JACC-CARDIOVASCULAR IMAGING (2011)
Cardiovascular and Renal Damage in Primary Aldosteronism: Outcomes After Treatment
Leonardo A. Sechi et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Rapid Reversal of Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With Resistant Hypertension and Hyperaldosteronism A Prospective Clinical Study
Krishna Gaddam et al.
HYPERTENSION (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Cardiovascular outcomes in patients with primary aldosteronism after treatment
Cristiana Catena et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Characterization of resistant hypertension - Association between resistant hypertension, aldosterone, and persistent intravascular volume expansion
Krishna K. Gaddam et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Inappropriate left ventricular mass in patients with primary aldosteronism
Maria Lorenza Muiesan et al.
HYPERTENSION (2008)
Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism
Cristiana Catena et al.
HYPERTENSION (2007)
Role of aldosterone in left ventricular hypertrophy in hypertension
K Matsumura et al.
AMERICAN JOURNAL OF HYPERTENSION (2006)
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
P Milliez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Extensive personal experience - Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
P Mulatero et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Prognostic significance of left ventricular mass change during treatment of hypertension
RB Devereux et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Hyperaldosteronism among with resistant black and white subjects hypertension
DA Calhoun et al.
HYPERTENSION (2002)
Aldosterone induces a vascular inflammatory phenotype in the rat heart
R Rocha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Aldosterone antagonist improves diastolic function in essential hypertension
AM Grandi et al.
HYPERTENSION (2002)
Share Paper
